Comparative in-vitro activity of MK0787 (N-formimidoyl thienamycin) against 540 blood culture isolates.
D000900:Anti-Bacterial Agents / Q000494:pharmacology*; D001419:Bacteria / Q000187:drug effects*; D002512:Cephalothin / Q000494:pharmacology; D002513:Cephamycins / Q000494:pharmacology; D006801:Humans; D015378:Imipenem; D007769:Lactams / Q000494:pharmacology; D008826:Microbial Sensitivity Tests; D009070:Moxalactam; D018805:Sepsis / Q000382:microbiology*; D014031:Tobramycin / Q000494:pharmacology
D000900:Anti-Bacterial Agents; D002513:Cephamycins; D007769:Lactams; D015378:Imipenem; D002512:Cephalothin; D009070:Moxalactam; D014031:Tobramycin